State‐dependent NMDA receptor antagonism by Ro 8‐4304, a novel NR2B selective, non‐competitive, voltage‐independent antagonist
Authors:
- 3 February 1998
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 123 (3) , 463-472
Abstract
Subunit‐selective blockade of N‐methyl‐D‐aspartate (NMDA) receptors provides a potentially attractive strategy for neuroprotection in the absence of undesirable side effects. Here, we describe a novel NR2B‐selective NMDA antagonist, 4‐{3‐[4‐(4‐fluoro‐phenyl)‐3,6‐dihydro‐2H‐pyridin‐1‐yl]‐2‐hydroxy‐propoxy}‐benzamide (Ro 8‐4304), which exhibits >100 fold higher affinity for recombinant NR1001/NR2B than NR1001/NR2A receptors. Ro 8‐4304 is a voltage‐independent, non‐competitive antagonist of NMDA receptors in rat cultured cortical neurones and exhibits a state‐dependent mode of action similar to that described for ifenprodil. The apparent affinity of Ro 8‐4304 for the NMDA receptor increased in an NMDA concentration‐dependent manner so that Ro 8‐4304 inhibited 10 and 100 μM NMDA responses with IC50s of 2.3 and 0.36 μM, respectively. Currents elicited by 1 μM NMDA were slightly potentiated in the presence of 10 μM Ro 8‐4304, and Ro 8‐4304 binding slowed the rate of glutamate dissociation from NMDA receptors. These results were predicted by a reaction scheme in which Ro 8‐4304 exhibits a 14 and 23 fold higher affinity for the activated and desensitized states of the NMDA receptor, respectively, relative to the agonist‐unbound resting state. Additionally, Ro 8‐4304 binding resulted in a 3–4 fold increase in receptor affinity for glutamate site agonists. Surprisingly, whilst exhibiting a similar affinity for NR2B‐containing NMDA receptors as ifenprodil, Ro 8‐4304 exhibited markedly faster kinetics of binding and unbinding to the NMDA receptor. This spectrum of kinetic behaviour reveals a further important feature of this emerging class of NR2B‐selective compounds. British Journal of Pharmacology (1998) 123, 463–472; doi:10.1038/sj.bjp.0701634Keywords
This publication has 29 references indexed in Scilit:
- Interactions between Ifenprodil and the NR2B Subunit of the N-Methyl-D-aspartate ReceptorJournal of Biological Chemistry, 1996
- Determination of NMDA NR1 subunit copy number in recombinant NMDA receptorsProceedings Of The Royal Society B-Biological Sciences, 1995
- Subtypes of NMDA receptor in neurones cultured from rat brainNeuroReport, 1994
- Changing subunit composition of heteromeric NMDA receptors during development of rat cortexNature, 1994
- Developmental and regional expression in the rat brain and functional properties of four NMDA receptorsNeuron, 1994
- Developmental switch in the expression of NMDA receptors occurs in vivo and in vitroNeuron, 1993
- The neuroprotective properties of ifenprodil, a novel NMDA receptor antagonist, in neuronal cell culture toxicity studiesEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAsNature, 1992
- Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-d-aspartate receptorNeuron, 1991
- Polyamine and ifenprodil interactions with the NMDA receptor's glycine siteEuropean Journal of Pharmacology: Molecular Pharmacology, 1991